Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05930769
Other study ID # 2022-CF016.
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date June 1, 2022
Est. completion date December 1, 2023

Study information

Verified date June 2023
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

ImpactRA is an observational retrospective study. The management of the patient is not modified by this study. This study will be carried out based on the already existing data of the gynecological ward of CHU Clermont-Ferrand between 2016 and 2021. During this period of time, 17 patients have undergone laparoscopy, with surgical indication of myomectomy or adenomyomectomy, aided by augmented reality (AR). The investigators compared these 17 patients that underwent surgery with AR with 17 control patients that underwent the same surgery with the same indication but without AR.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 49
Est. completion date December 1, 2023
Est. primary completion date September 22, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 84 Years
Eligibility Inclusion Criteria: - Age between 18 (included) and 84 (Included), - Patient operated between 2017* et 2021, - Patient with one or more intrauterine myomas, with surgical treatment by laparoscopic myomectomy with or without AR, - Patient with one or more intrauterine adenomyomas, with surgical treatment by laparoscopic adenomyomectomy with or without AR, - Patient informed about the use of her data for research. Exclusion Criteria: - Patient who refused the use of medical data for research purposes, - Patient operated prior to 2017* and after 2021, - Patient whose medical follow-up did not allow collection of the data required for the study. (*) An amendment validated by the ethics committee allows inclusion of patients operated during 2016

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Gynecological laparoscopic surgery without augmented reality
Minimally invasive gynecological surgery assisted by laparoscope.
Gynecological laparoscopic surgery with augmented reality
Minimally invasive gynecological surgery assisted by laparoscope with the display of additional information through augmented reality.

Locations

Country Name City State
France CHU clermont-ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Operation duration (in minute) Assessment of the use of augmented reality during gynecologic laparoscopy defined by the non-increase of the operation time. In the intra-operative phase of the study
Secondary Amount of bleeding (in mL) Estimating the impact of AR on the amount of bleeding In the intra-operative phase of the study
Secondary Post-operative pain measured with the visual analogue scale (VAS) score (measure every day after the operation as well as at the end of hospitalization). Estimating the impact of AR on the pain measured with the post-operative visual analogue scale (VAS) score. The score on this scale ranges from 0 to 10. The higher the score, the more pain the patient experienced at the time of filling in the scale. In the post-operative phase of the study
Secondary Intra-operative complication number and details (wounds of adjacent structures and organs, vascular wounds, opening of the uterine cavity, difficulties in locating the tumor) based on the comments of the surgical report Estimating the impact of AR on the intra-operative complication rate In the intra-operative phase of the study
Secondary Conversion from laparoscopy to laparotomy Estimating the impact of AR on the conversion rate (laparoscopy to laparotomy) In the intra-operative phase of the study
Secondary Comments related to the set up of AR (according to the surgical report) Estimating the impact of AR in the operating room represented by its installation and use during the course of the surgical procedure and estimating the impact of AR on the complexity/difficulty of the procedure recorded in the surgical report In the intra-operative phase of the study
Secondary Total time of hospitalization (in day) Estimating the impact of AR on hospitalization duration From the date of hospital admission to the date of hospital discharge assessed up to 1 week
Secondary Time between discharge from hospital and the last post-operative visit (in months) Estimating the impact of AR on the time between discharge from hospital and the last post-operative visit (in months) From the date of hospital discharge to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
Secondary Pregnancy obtention follow-up Estimating the impact of AR on the frequency of post-operative pregnancy From the date of surgery to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
Secondary Adenomyosis / myoma(s) recurrence from 6 months after the operation ; Estimating the impact of AR on the frequency of recurrence greater than 6 months From the date of the surgery to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
Secondary Post-operative complications numbers and details (wounds of adjacent structures and organs, bleeding complications, reoperations, complications based on the Clavien-Dindo classification) based on the comments of the post-operative consultation Estimating the impact of AR on the post-operative complication rate From the date of the surgery to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
See also
  Status Clinical Trial Phase
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Active, not recruiting NCT06114758 - Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
Not yet recruiting NCT05967936 - Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy N/A
Not yet recruiting NCT05932082 - The Impact of Myomectomy on IVF Outcomes N/A
Recruiting NCT04748978 - OPPIuM Technique and Myolysis With Diode Laser Dwls N/A
Recruiting NCT05271981 - Fertility After Uterine Artery Embolization
Completed NCT05025410 - Remimazolam and Remifentanil Without Neuromuscular Blocking Agent
Recruiting NCT03483142 - the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation Phase 3
Completed NCT03533907 - Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.
Completed NCT05811286 - The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study N/A
Not yet recruiting NCT03570879 - Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens.
Not yet recruiting NCT04364581 - Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions Phase 4
Recruiting NCT06067971 - Evaluation of the Feasibility of Using Augmented Reality in Laparoscopic Surgery, by a Clinical Study During Gynecological Laparoscopic Surgical Procedures. (ENDORA2) N/A
Recruiting NCT04990076 - Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
Recruiting NCT06325501 - Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy Phase 3
Completed NCT05761418 - Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy Phase 3
Recruiting NCT04311073 - Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies Phase 3
Recruiting NCT03550703 - Open Label Immunotherapy of Myoma Phase 2
Completed NCT04482959 - Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy Phase 4
Not yet recruiting NCT04030273 - Prevalence of Intrauterine Adhesions After Abdominal Myomectomy